全球生命科学
概述
Featured News & Insights
0015
Contacts
Services
Advising on the full scope of regulatory, compliance and enforcement, litigation and transactional matters, we can offer you a holistic legal approach that will smooth your path as you navigate industry changes, technological advances, market demands and policy hurdles.
Regions
From high-profile transactions to regulatory issues and complex litigation, we collaborate across borders and disciplines to help our clients in more than 70 countries face challenges and embrace opportunities.

All Professionals
sort
Capabilities
Related Resources
Related Blogs
News & Insights
FDA’s Elsa at Eleven Months: AI-Powered Operations and One-Day Inspections Signal a New Oversight ParadigmMay 20, 2026Sidley Sponsors the 2026 EU Pharma Law ForumTuesday, May 19, 2026 – Thursday, May 21, 2026Sidley Represents Nourish in US$100 Million Series C FinancingMay 19, 2026Women’s Life Sciences Network – Biotech Act: Funding and Investment OpportunitiesTuesday, May 19, 2026
GoodLifeSci
活动
公告
活动
SEC Proposes Optional Semiannual Reporting Regime: What Companies Should Consider NowMay 7, 2026New Guidance on U.S. Procurement Raises Risk to Federal Contractors From Potentially Discriminatory PracticesApril 29, 2026Most-Favored-Nation Drug Pricing Policy: Executive Actions, Manufacturer Agreements, and Growing Congressional ScrutinyApril 22, 2026U.S. FDA Issues First Drug Supply Chain Security Act Warning Letter Targeting a Dispenser, Signaling Expanded Enforcement FocusApril 15, 2026
Public Company Advisory Update
Healthcare and White Collar Update
Global Life Sciences Update
Food, Drug, and Medical Device Update
Securities Class Actions in the Life Sciences SectorSpring 2026Congress Passes Significant Federal Pharmacy Benefit Manager Reform Impacting Pharmaceutical Market AccessApril 9, 2026FDA's Crackdown On Drug Ads Conflicts With PrecedentApril 2, 2026Drug Pricing and Medicaid Rebate Reporting: Enforcement Risk RemainsFebruary 17, 2026
出版专著
Westlaw Today
Law360
Reuters
Sidley Sponsors the 2026 EU Pharma Law ForumTuesday, May 19, 2026 – Thursday, May 21, 2026Women’s Life Sciences Network – Biotech Act: Funding and Investment OpportunitiesTuesday, May 19, 2026Growth Meets Guardrails: Getting You Ready for the New Realm of Ad/PromoWednesday, May 13, 2026Global Trial Expansion — Key Considerations for EU/U.S. SponsorsApril 21, 2026
活动
活动
活动
活动
Sidley Represents Nourish in US$100 Million Series C FinancingMay 19, 2026Sidley Represents Rigel Pharmaceuticals in Exclusive Global License Agreement with Pfizer and Arvinas for VEPPANUMay 13, 2026Sidley Represents MacroGenics in the Sale of Its GMP Manufacturing OperationsMay 11, 2026Sidley Represents Underwriters in Connection With Pharvaris’ US$115 Million Underwritten Offering of Ordinary SharesMay 8, 2026
公告
公告
公告
公告
FDA’s Elsa at Eleven Months: AI-Powered Operations and One-Day Inspections Signal a New Oversight ParadigmMay 20, 2026EU Pharma Package: Compromise Text Published – Best Efforts Required (Part 2)May 18, 2026DOJ Announces FOCUS Initiative to Work with Data Miners Filing Qui TamsApril 30, 2026Navigating the European Health Data Space Regulation: An (Uneasy) Marriage Between EHDS and GDPR (April 2026, Part 2)April 14, 2026
GoodLifeSci
GoodLifeSci
Original Source
GoodLifeSci





































